Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rob Ter Heine

Showing results (61-70 of 160) with videos related to

Pageof 16
Sort By:
Journal of Comparative Effectiveness Research|November 2, 2017
Cost of illness of metastatic prostate cancer: a perspective of costs for new treatment options in The NetherlandsRob Ter Heine, Geert Wj Frederix, Joost W Geenen, et al.
Clinical Pharmacokinetics|October 11, 2023
Population Pharmacokinetics of Total and Unbound Isavuconazole in Critically Ill Patients: Implications for Adaptive Dosing StrategiesAnouk M E Jansen, Beatrijs Mertens, Isabel Spriet, et al.
Parasites & Vectors|October 10, 2021
Model-based assessment of the safety of community interventions with primaquine in sub-Saharan AfricaStijn W van Beek, Elin M Svensson, Alfred B Tiono, et al.
Therapeutic Drug Monitoring|July 27, 2019
Simple and Rapid Quantification of the Multi-Enzyme Targeting Antifolate Pemetrexed in Human PlasmaErik van den Hombergh, Nikki de Rouw, Michel van den Heuvel, et al.
Cancer Chemotherapy and Pharmacology|January 19, 2026
Mapping drug-drug interactions in pharmacokinetic boosting of olaparibJoanneke K Overbeek, Sarmad M S Naoom, Laura Nijboer, et al.
Journal of Psychopharmacology (Oxford, England)|March 22, 2024
The pharmacokinetics and pharmacodynamics of ibogaine in opioid use disorder patientsThomas Knuijver, Rob Ter Heine, Arnt F A Schellekens, et al.
Clinical Pharmacokinetics|June 15, 2016
A Semi-Physiological Population Model to Quantify the Effect of Hematocrit on Everolimus Pharmacokinetics and Pharmacodynamics in Cancer PatientsNielka P van Erp, Carla M van Herpen, Djoeke de Wit, et al.
Antiviral Therapy|May 12, 2009
Prolonged exposure to tenofovir monotherapy 1 month after treatment discontinuation because of tenofovir-related renal failureRob Ter Heine, Alwin Dr Huitema, Robert S Jansen, et al.
Biomedical Chromatography : BMC|August 13, 2024
Development and validation of an ultra-performance liquid chromatography-tandem mass spectrometry method to quantify the small molecule inhibitors adagrasib, alectinib, brigatinib, capmatinib, crizotinib, lorlatinib, selpercatinib, and sotorasib in human plasmaEsther M Hollander, Nachel M C Zimmerman, Berber Piet, et al.
Clinical Pharmacokinetics|May 25, 2025
Optimizing Nortriptyline Dosing: A Comparison between Pharmacogenetics-Based, Phenotype-Based, and Standard DosingCornelis F Vos, Marieke J H Coenen, Sophie E Ter Hark, et al.
Pageof 16

Showing results (61-70 of 160) with videos related to

Sort By:
Pageof 16
Journal of Comparative Effectiveness Research|November 2, 2017
Cost of illness of metastatic prostate cancer: a perspective of costs for new treatment options in The NetherlandsRob Ter Heine, Geert Wj Frederix, Joost W Geenen, et al.
Clinical Pharmacokinetics|October 11, 2023
Population Pharmacokinetics of Total and Unbound Isavuconazole in Critically Ill Patients: Implications for Adaptive Dosing StrategiesAnouk M E Jansen, Beatrijs Mertens, Isabel Spriet, et al.
Parasites & Vectors|October 10, 2021
Model-based assessment of the safety of community interventions with primaquine in sub-Saharan AfricaStijn W van Beek, Elin M Svensson, Alfred B Tiono, et al.
Therapeutic Drug Monitoring|July 27, 2019
Simple and Rapid Quantification of the Multi-Enzyme Targeting Antifolate Pemetrexed in Human PlasmaErik van den Hombergh, Nikki de Rouw, Michel van den Heuvel, et al.
Cancer Chemotherapy and Pharmacology|January 19, 2026
Mapping drug-drug interactions in pharmacokinetic boosting of olaparibJoanneke K Overbeek, Sarmad M S Naoom, Laura Nijboer, et al.
Journal of Psychopharmacology (Oxford, England)|March 22, 2024
The pharmacokinetics and pharmacodynamics of ibogaine in opioid use disorder patientsThomas Knuijver, Rob Ter Heine, Arnt F A Schellekens, et al.
Clinical Pharmacokinetics|June 15, 2016
A Semi-Physiological Population Model to Quantify the Effect of Hematocrit on Everolimus Pharmacokinetics and Pharmacodynamics in Cancer PatientsNielka P van Erp, Carla M van Herpen, Djoeke de Wit, et al.
Antiviral Therapy|May 12, 2009
Prolonged exposure to tenofovir monotherapy 1 month after treatment discontinuation because of tenofovir-related renal failureRob Ter Heine, Alwin Dr Huitema, Robert S Jansen, et al.
Biomedical Chromatography : BMC|August 13, 2024
Development and validation of an ultra-performance liquid chromatography-tandem mass spectrometry method to quantify the small molecule inhibitors adagrasib, alectinib, brigatinib, capmatinib, crizotinib, lorlatinib, selpercatinib, and sotorasib in human plasmaEsther M Hollander, Nachel M C Zimmerman, Berber Piet, et al.
Clinical Pharmacokinetics|May 25, 2025
Optimizing Nortriptyline Dosing: A Comparison between Pharmacogenetics-Based, Phenotype-Based, and Standard DosingCornelis F Vos, Marieke J H Coenen, Sophie E Ter Hark, et al.
Pageof 16